About the Conference:
New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.
CONFERENCE'S MAIN SCIENTIFIC TOPICS
• Molecular pathogenesis of MPNs
• Novel MPN therapeutics targets
• MPN clonal evolution
• MPN models and pathogenesis/therapeutic studies
• New therapies and challenges in the management of MPN
• Update on therapeutic approaches in MPN
• Update in MPN diagnostics
• CALR Mutations in MPN Pathogenesis and Therapy
• Polycythemias
THE PROGRAMME WILL INCLUDE:
Keynote Lectures -Plenary Sessions - Panel Discussions
Simultaneous Meet the Expert Sessions
Mentored Poster Walks - Brief Oral Communications
This educational conference has been approved for 18 CME-CPD credit points
by the European Board for Accreditation in Haematology (EBAH)!
CLICK HERE FOR MORE INFORMATION
With the support of*:
Level 1 Conference Partner
*******
Level 2 Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.